affron® a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial.
Complement Ther Med
; 33: 58-64, 2017 Aug.
Article
em En
| MEDLINE
| ID: mdl-28735826
ABSTRACT
BACKGROUND:
In recent years phytotherapy has been explored as a source for alternative treatments for mood disorders. One potential candidate is saffron (Crocus sativus L.), whose main bioactive components are crocins and safranal.OBJECTIVES:
The aim of this study was to investigate the efficacy of affron®, a standardised stigmas extract from Crocus sativus L. for improving mood, stress, anxiety and sleep quality in healthy adults.METHODS:
In this 3 arm study, 128 participants self-reporting low mood but not diagnosed with depression, were given affron® at 28mg/day, 22mg/day, or a placebo treatment in a randomized, double-blind, placebo-controlled trial for 4 weeks. Mood was measured at baseline and at the end of the study, using the POMS (primary outcome measure) and PANAS questionnaires, and the DASS-21 scale. Sleep was monitored using Sleep Quality Index (PSQI).RESULTS:
Analysis indicated a significant decrease in negative mood and symptoms related to stress and anxiety at a 28mg/day dose (with a significant difference between 28mg/day and placebo on the POMS Total Mood Disturbance scale, p<0.001, d=-1.10), but no treatment effect at the 22mg/day dose.LIMITATIONS:
The main weaknesses of this investigation were found in the self-reporting nature of both the screening and the testing.CONCLUSIONS:
affron® increased mood, reduced anxiety and managed stress without side effects, offering a natural alternative to standard treatments.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Ansiedade
/
Estresse Psicológico
/
Extratos Vegetais
/
Afeto
/
Crocus
/
Depressão
/
Fitoterapia
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article